SCHEMBL7723972

SCHEMBL7723972

Cc1ccc(S(=O)(=O)OCCCc2ccc(Cl)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.54
FKBP1A P62942 1/20 0.52
BCHE P06276 1/20 0.49
ACHE P22303 1/20 0.49
LMNA P02545 2/20 0.48
HTT P42858 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
CYP2C19 P33261 1/20 0.48
KCNH2 Q12809 1/20 0.48
HIF1A Q16665 1/20 0.48
KMT2A Q03164 5/20 0.48
ALDH1A1 P00352 3/20 0.47
GAA P10253 2/20 0.47
MEN1 O00255 2/20 0.45
EGFR P00533 1/20 0.45
ERBB2 P04626 1/20 0.45
MAPT P10636 1/20 0.43
PSMD10 O75832 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11203640 0.94 LMNA (0.52) CNR2FKBP1ABCHEACHELMNA
SCHEMBL2567795 0.92 ALDH1A1 (0.47) CNR2FKBP1ALMNACYP2C9CYP2C19
SCHEMBL18934371 0.92 ALDH1A1 (0.47) CNR2FKBP1ALMNACYP2C9CYP2C19
SCHEMBL948326 0.91 CNR2 (0.56) CNR2FKBP1ABCHEACHELMNA
SCHEMBL18926560 0.88 GAA (0.50) CNR2FKBP1ABCHEACHELMNA
SCHEMBL18926554 0.87 CA2 (0.53) CNR2LMNAHTTCYP2D6CYP2C9
SCHEMBL4793354 0.85 FKBP1A (0.52) CNR2FKBP1ABCHEACHECYP2C9
SCHEMBL7028389 0.85 CNR2 (0.50) CNR2FKBP1ABCHEACHELMNA
SCHEMBL11201096 0.85 ALDH1A1 (0.50) CNR2FKBP1ALMNAHTTCYP2D6
SCHEMBL8780852 0.84 FKBP1A (0.53) CNR2FKBP1ABCHEACHEHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468998-B1 ANTAGONIZE SEROTONIN 2 RECEPTORS, SUPPRESS PLATELET AGGREGATION, IMPROVE PERIPHERAL CIRCULATION AND PROMOTE LACHRYMATION MITSUBISHI PHARMA CORPORATION (JP) 2002-10-22 US disclosed
EP-1125922-A1 PYRROLIDINE COMPOUNDS AND MEDICINAL UTILIZATION THEREOF Welfide Corporation (JP) 2001-08-22 EP disclosed
EP-0697407-B1 Pyrimidinedione derivatives and antiarrhythmic compositions containing same MITSUI TOATSU CHEMICALS (JP) 1997-06-25 EP disclosed
EP-0697407-A1 Pyrimidinedione derivatives and antiarrhythmic compositions containing same MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-02-21 EP disclosed
EP-0038343-B1 SUBSTITUTED CARBOXYLIC CETO-ACIDS, PROCESS FOR THE PREPARATION THEREOF, USE THEREOF AND MEDICINAL COMPOSITIONS CONTAINING THEM Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1984-12-27 EP disclosed
EP-0025192-B1 SUBSTITUTED OXIRANE CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION, THEIR USE AND MEDICINES CONTAINING THEM Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1983-05-11 EP disclosed
US-4334089-A HYPOGLYCEMIC AGENTS BYK GULDEN LOMBERG CHEMISCHE FABRIK GESELLSCHAFT (DE) 1982-06-08 US disclosed
EP-0051077-A1 Substituted oxocarboxylic acids, process for their preparation, their use and medicines containing them Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1982-05-12 EP disclosed
EP-0038343-A1 SUBSTITUTED CARBOXYLIC CETO-ACIDS, PROCESS FOR THE PREPARATION THEREOF, USE THEREOF AND MEDICINAL COMPOSITIONS CONTAINING THEM. BYK GULDEN LOMBERG CHEM FAB (DE) 1981-10-28 EP disclosed
WO-1981001285-A1 SUBSTITUTED CARBOXYLIC CETO-ACIDS,PROCESS FOR THE PREPARATION THEREOF,USE THEREOF AND MEDICINAL COMPOSITIONS CONTAINING THEM BYK GULDEN LOMBERG CHEM FAB (DE) 1981-05-14 WO disclosed
EP-0025192-A2 Substituted oxirane carboxylic acids, process for their preparation, their use and medicines containing them Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1981-03-18 EP disclosed